Previous studies have found associations between one-carbon metabolism nutrients and risk of several cancers, but little is known regarding upper gastrointestinal tract (UGI) cancer. We analyzed prediagnostic serum concentrations of several onecarbon metabolism nutrients (vitamin B12, folate, vitamin B6, riboflavin and homocysteine) in a nested case-control study within the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study of male smokers, which was undertaken in Finland between 1985 and 1988. We conducted a nested case-control study including 127 noncardia gastric adenocarcinoma (NCGA), 41 esophagogastric junctional adenocarcinoma and 60 esophageal squamous cell carcinoma incident cases identified within ATBC. Controls were matched to cases on age, date of serum collection and follow-up time. One-carbon nutrient concentrations were measured in fasting serum samples collected at baseline (up to 17 years prior to cancer diagnosis). Odds ratios and 95% confidence intervals (CI) were calculated using conditional logistic regression. Lower prediagnostic vitamin B12 concentrations at baseline were associated with a 5.8-fold increased risk of NCGA (95% CI 5 2.7-12.6 for lowest compared to highest quartile, p-trend <0.001). This association remained in participants who developed cancer more than 10 years after blood collection, and after restricting the analysis to participants with clinically normal serum vitamin B12 (>300 pmol/L). In contrast, pepsinogen I, a known serologic marker of gastric atrophy, was not associated with NCGA in this population. As vitamin B12 absorption requires intact gastric mucosa to produce acid and intrinsic factor, our findings suggest vitamin B12 as a possible serologic marker for the atrophic gastritis that precedes NCGA, one more strongly associated with subsequent NCGA than pepsinogen. One-carbon metabolism nutrients could play an etiological role in UGI tract cancer through several mechanisms. Onecarbon reactions generate purines and pyrimidines for DNA synthesis and repair, and generate the methyl groups needed for methylation of DNA, RNA and protein. Perturbing these crucial functions could promote carcinogenesis. Several B vitamins are essential to the one-carbon metabolism pathway as cofactors and prosthetic groups: cobalamin (vitamin B12), folate (vitamin B9), pyridoxine (vitamin B6) and riboflavin (vitamin B2). Homocysteine is a metabolite of the pathway, wherein it is converted to methionine.
serum vitamin B12 and a 0.78-fold decreased risk of gastric cancer per SD increase in serum vitamin B6. 13, 15 We measured serum concentrations of several one-carbon nutrients (vitamin B12, folate, vitamin B6, riboflavin and homocysteine) in 253 UGI cancer cases:127 cases of noncardia gastric adenocarcinoma (NCGA), 46 cases of esophagogastric junctional adenocarcinoma (EGJA), 60 cases of esophageal squamous cell carcinoma (ESCC) and 326 controls, in a case-control study nested within the AlphaTocopherol, Beta-Carotene Cancer Prevention (ATBC) Study.
Methods

Study cohort
The ATBC Study, a randomized controlled trial conducted in Finland, was designed to investigate whether daily supplementation with alpha-tocopherol, beta-carotene or both could reduce the risk of lung and other cancers. 16, 17 The study population included 29,133 male smokers (5 cigarettes/day), ages 50-69 years, from Finland who were recruited and randomized between 1985 and 1988. Participants were excluded from the trial if they had a history of a malignancy or other medical conditions that could limit long-term participation. After the end of the trial in 1993, participants were followed as a cohort. Written informed consent was obtained from all individuals. The study was approved by the Special Studies IRB at the National Cancer Institute and by the IRBs at the National Public Health Institute in Finland.
Baseline data collection (1985) (1986) (1987) (1988) Prior to randomization, participants completed questionnaires on general background characteristics (smoking habits, diet, lifestyle, education and medical history). During the baseline assessment (prerandomization to alpha-tocopherol, beta-carotene supplements), participants provided a 12 hr fasting blood sample. Serum samples were stored at 2708C until analyzed. Participants completed a validated dietary assessment instrument, which assessed usual food consumption over the previous year. 18 The food frequency questionnaire was completed satisfactorily by 93% of study participants. Participants missing dietary data were included in analyses with a "missing" indicator variable. Excluding these participants from the study did not affect risk estimates (data not shown).
Case identification and control selection (follow-up through 2002)
Cancer cases were identified through the Finnish Cancer Registry, which provides almost 100% ascertainment of cancer cases in the ATBC Cohort. 19 Cases were defined as incident tumors of the esophagus (ICD9 code 150), gastric cardia (ICD9 code 151.0) or incident gastric tumors not in the cardia (ICD9 code 151.1). ICDO codes were further used to classify histology. We classified EGJA patients according to the World Health Organization classification of tumors of the digestive system 20 : adenocarcinomas of the esophagus and gastric cardia. All cases were diagnosed between study baseline and April 30, 2002, with adequate serum. To be eligible for selection, controls had to be alive and cancer-free at the time of case diagnosis. Three hundred and thirty controls were matched to the 330 UGI selected cancer cases at 1:1 on age at randomization (6 5 years) and date of blood draw (6 30 days). Of these, 326 controls and 253 cases (127 NCGA, 46 EGJA, 60 ESCC and 20 additional cases of mixed histology (carcinomas, carcinoid and sarcomas) were excluded from the site-specific analyses) had serum available for analysis. Here, we present results using all 326 controls, rather than only the 253 matched controls, because they add precision to our point estimates, though we note that our estimates were similar when we included only the 253 matched controls (Supporting Information, Table 1 ). The median follow-up time for participants was 13 years and the maximum follow-up was 17 years.
Laboratory analysis
Serum folate and vitamin B12 were determined by radioassay (Bio-Rad Laboratories). Pyridoxal 5 0 phosphate (PLP), the biologically active form of vitamin B6, was determined by the tyrosine decarboxylase apoenzyme method. 21 Homocysteine and riboflavin were determined by high-performance liquid chromatography. 22, 23 Each batch contained case and matched control pairs placed adjacently but in random order, and six blinded quality control (QC) samples derived from a pool of serum. For the QC samples, the within-batch coefficients of variation were 6.1% for homocysteine, 5.3% for vitamin B6, 9.3% for folate, 6.8% for vitamin B12 and 5.8% for riboflavin (25 batches, 154 QC samples, 5-7 QC samples per batch).
H. pylori seropositivity was measured by a multiplex serology assay that determined presence of serum antibodies to 15
What's new? B vitamins are crucial for DNA methylation, synthesis and repair. Might they lower the risk of upper gastrointestinal tract (UGI) cancers? In this study, the authors found that low serum B12 was associated with a fivefold increase in risk of noncardia gastric adenocarcinoma. Low B12 was also more strongly associated with gastric cancer than pepsinogen I, a serologic marker of gastric atrophy. Low serum B12 may thus provide a valuable marker for assessing future UGI cancer risk, and also for identifying the atrophic gastritis that precedes these cancers.
Cancer Epidemiology
Miranti et al.
H. pylori-specific antigens. We defined overall H. pylori positivity as those seropositive to four or more antigens. 24, 25 Serum pepsinogen I was measured via radioimmunoassay.
26-28 A low serum pepsinogen I level was defined as 25 mg/L or less. 29 
Statistical analysis
Statistical analyses were performed using Stata version 13.0 (Stata-Corp LP) and all p values were two-sided. Serum nutrient quartiles were based on the distribution among the controls. We compared the distribution of selected characteristics for case and 1:1 matched control subjects using Wilcoxon rank-sum tests for continuous variables and v 2 test for categorical variables. Among controls, the associations between serum one-carbon nutrients (in quartiles) and selected characteristics were determined by the nonparametric tests for trend. Correlations between individual pairs of one-carbon nutrients were estimated using Spearman's rank order coefficient among the control subjects.
Odds ratios (OR) and 95% confidence intervals (CI) for the association between serum one-carbon nutrients and incident cancer were determined by conditional logistic regression with the highest quartile as referent. For continuous models, serum nutrient concentrations were scaled to 1 = 2 the interquartile range (a scale which is appropriate for data which is not normally distributed) of that nutrient in controls.
On inspection, the laboratory measurements of the onecarbon metabolites showed significant drift across analytic batches. To account for this analytic measurement drift, we broke the original matching scheme (age and date of blood draw) and conditioned the logistic regression models on analytic batch. This approach produced similar results to matching by pair number, as cases and their matched controls were always included within the same batch.
Models were adjusted for age (years), BMI (body mass index, kg/m 2 ), number of cigarettes smoked per day, years of cigarette smoking, educational attainment (educated beyond elementary school, %), alcohol consumption (g/day), energy intake (kcal/day), fruit (g/day) and vegetable (g/day) consumption, H. pylori seropositivity and low pepsinogen 1 status (PGI; 25 mg/L). Models were additionally adjusted for milk and meat consumption, and ATBC assignment during preliminary analysis, though they were not included in final models because intake did not differ between cases and controls and addition of these elements to the models did not significantly change estimates.
Though case numbers were low for subgroup analysis, we examined possible effect modification by smoking dose (/< mean: 20 cigarettes/day), years of smoking (/< mean: 37 years) and alcohol consumption (<13 g/day, 13-26 g/day and 26 g/day) using unconditional logistic regression.
For the NCGA/vitamin B12 disease association model, lag analysis was also performed: NCGA patients were classified according to whether they occurred within 2 years of baseline, within 10 years of baseline or >10 years after baseline. We also performed a sensitivity analysis on this model, excluding vitamin B12 borderline and deficient participants (<300 pmol/L).
Results
Baseline characteristics for cancer cases and controls are shown in Table 1 . Compared to controls, NCGA cases had higher prevalence of H. pylori seropositivity and lower serum vitamin B12, folate and vitamin B6. EGJA cases started smoking at an older age than controls. ESCC cases had lower BMI, higher alcohol consumption and higher prevalence of H. pylori seropositivity and low pepsinogen I compared with controls.
Among all subjects (regardless of case/control status), 2% had deficient serum vitamin B12 (<150 pmol/L) 30 ; 35% had borderline/below-sufficient vitamin B12 (<300 pmol/L) 31 ; 33% had deficient serum folate (<7.5 nmol/L) 30 ; 84% had borderline/below-sufficient serum folate (<12.0 nmol/L) 30 ; 66% had deficient serum vitamin B6 (<30 pmol/mL) 30 . Homocysteine was elevated (>15 nmol/mL) 32 in 34% of subjects. There is no defined adequacy level for serum riboflavin.
Weak but statistically significant correlations were observed among the serum nutrients within controls (Table  2) , including for vitamin B12, which was positively correlated with folate, vitamin B6 and riboflavin, and negatively correlated with homocysteine. The associations between serum one-carbon nutrient concentrations and baseline characteristics were analyzed in controls (Supporting Information, Table 2 ). Table 3 presents the odds ratios for the association between baseline serum one-carbon nutrient concentrations and NCGA, EGJA or ESCC. We present the results of three models: a crude model, a model fully adjusted for established risk-factors for UGI cancer and a model additionally adjusted for H. pylori seropositivity and pepsinogen I status. Results from the three models were similar, although the confidence intervals for the associations reported in the additionally adjusted model are notably wider. This was likely due to the fact that our population had a very low proportion of H. pylori seronegativity, and low prevalence of low PG I status. The fully adjusted model was the most parsimonious. Compared to those with the highest (Q4) serum vitamin B12 concentration, participants with lower serum vitamin B12 had significantly elevated risk of NCGA (Table 3 : Q1 vs 4: OR: 5.77; 95% CI: 2.65, 12.56, p trend < 0.001). This association between low vitamin B12 and an increased risk of NCGA remained statistically significant across all three models.
Conversely, low serum folate concentrations were associated with a decreased risk of EGJA in the additionally adjusted model only (Q1 vs 4: OR: 0.05; 95% CI: 0.00-0.72, p trend 5 0.04), although the case numbers for EGJA are small (n 5 41) and the confidence intervals wide. None of the other one-carbon nutrients were associated with NCGA, EGJA or ESCC. Furthermore, there was no evidence of interactions of Cancer Epidemiology any of the associations by smoking dose (<20 vs 20 cigarettes/day), years of smoking (<37 vs 37 years) or alcohol consumption (<13, 13-26, 26 g/day). The temporal nature of the associations between vitamin B12 and NCGA was explored by performing a lag analysis (Table 4 ). Owing to small case numbers in some strata, we used a continuous model scaled to 1 = 2 the interquartile range in controls (73 pmol/L), rather than a quartile-based model. The magnitude of the association between serum vitamin B12 and NCGA appeared consistent over time, even after restricting the analysis to participants who developed cancer >10 years after blood collection.
Next, we performed a sensitivity analysis excluding cases and controls with vitamin B12 <300 pmol/L, thereby excluding both vitamin B12-deficient and borderline participants ( Table 5 ). The association between lower (Q2 or Q3, relative to Q4) serum B12 concentrations and increased risk of NCGA remained with these deficient and borderline participants removed.
Finally, we compared the association between low serum vitamin B12 and NCGA, with the association between low serum pepsinogen I, a known serologic marker of gastric atrophy, and NCGA (Table 6 ). The association between low serum vitamin B12 and NCGA was significant across all time intervals analyzed, even when adjusting for low pepsinogen I. In contrast, in the ATBC population, there was no association between low pepsinogen I and NCGA.
Discussion
We conducted a nested case-control study in the ATBC study to examine the association between the serum concentrations of one-carbon nutrients and NCGA, EGJA and ESCC. We observed a statistically significant 5.8-fold increase in risk of NCGA for subjects with lowest-quartile serum vitamin B12 (<291 pmol/L), relative to those with highestquartile serum vitamin B12 (>436 pmol/L). This association remained statistically significant regardless of how soon after the blood draw the cancers occurred, and increased risk of NCGA persisted even when individuals with clinically deficient and borderline B12 concentrations (<300 pmol/L) were omitted from the analysis. Low serum folate concentrations were associated with a decreased risk of EGJA in one of our three risk models, though we note that these associations are based on relatively small numbers. There were no statistically significant associations between ESCC and serum concentrations of any of the one-carbon nutrients.
The relationship between UGI cancer and serum concentrations of one-carbon nutrients has previously been studied prospectively in only the EPIC cohort, [13] [14] [15] wherein investigators found an association between low serum vitamin B12 and gastric cancer in cases with serologic evidence of gastric atrophy (n 5 44 cases, Q4 vs 1 OR:0.08; 95% CI: 0.02, 0.38, p trend 5 0.002), 15 and an association between low vitamin B6 and gastric cancer overall (n 5 235 cases, Q4 vs 1 OR: 0.46; 95% CI: 0.26, 0.80, p trend 5 0.006). 13 Our results were similar: we also found a strikingly increased risk of gastric cancer, specifically NCGA, in subjects with lower serum vitamin B12 concentrations. While we did not observe any associations between UGI tract cancer and serum vitamin B6 concentration, median vitamin B6 was 59% lower in our study population than the EPIC study population, meaning our analysis might not have had the dynamic range to observe a similar association. Also, by contrast, the ATBC study participants were (on average) younger than EPIC cohort members, they were all smokers and all males, meaning that there are many reasons to expect different serologic vitamin concentration profiles between the two studies. That low serum vitamin B12 is associated with an increased risk of NCGA is mechanistically plausible. The prevailing model for intestinal type gastric cancer describes a progression from chronic superficial gastritis, to chronic atrophic gastritis, to intestinal metaplasia, dysplasia, and finally adenocarcinoma. 33, 34 Chronic atrophic gastritis decreases gastric acid secretion. 35 In parallel, vitamin B12 absorption requires an acid-producing gastric mucosa, to allow cleavage of vitamin B12 from its binding proteins in the stomach. 36 Therefore, any stimulus which induces chronic atrophic gastritis could potentially increase the risk of NCGA and simultaneously diminish vitamin B12 absorption, and therefore serum concentration. Accordingly, within our population, lower serum concentrations of vitamin B12 were associated with higher prevalence of low pepsinogen I status, a known serologic measure of gastric atrophy 27 (Supporting Information, Table 1 ). However, we find it intriguing that within this population, the association between vitamin B12 and NCGA appears stronger than that seen for pepsinogen I. Unadjusted: crude odds ratios are calculated from conditional logistic regression models (conditioned on batch).
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Fully adj: multivariable adjusted odds ratios are from conditional logistic regression models (conditioned on batch) adjusted for age, BMI, number of cigarettes smoked, years of cigarette smoking, educational attainment, alcohol consumption, energy intake, fruits and vegetables
(not H. pylori or pepsinogen). 3 Additional adj: multivariable adjusted odds ratios are from conditional logistic regression models (conditioned on batch) adjusted for age, BMI, number of cigarettes smoked, years of cigarette smoking, educational attainment, alcohol consumption, energy intake, fruits, vegetables and H. pylori positivity by multiplex and low pepsinogen. 4 Cutpoints for quartiles were defined by all the controls used in the study. 5 Continuous models are scaled to 1 =2 the interquartile range in controls.
H. pylori infection is the strongest known initiator of the neoplastic sequence that leads to NCGA. 37, 38 H. pylori infection is also associated with food-bound vitamin B12 malabsorption [39] [40] [41] likely due to induction of atrophic gastritis and accompanying achlorhydria (increase in gastric pH). In turn, eradicating H. pylori infection has been shown to improve vitamin B12 status. 39 The prevalence of serologic positivity to H. pylori in our study population was very high (89% in controls and 99% in NCGA cases), thus H. pylori was likely the initiator that led to both poor vitamin B12 absorption, and ultimately NCGA, in our study population.
Pernicious anemia represents another potential link between vitamin B12 malabsorption and increased risk of NCGA. 42 Pernicious anemia is the end-stage of chronic autoimmune atrophic gastritis, in which antibodies to gastric parietal cells inhibit the secretion of intrinsic factor, eventually leading to macrocytic anemia due to diminished vitamin B12 absorption. It is possible that some subjects in our study had autoimmune atrophic gastritis, but without the knowledge of their antiparietal cell antibody status, we cannot know for certain. However, given that the prevalence of undiagnosed pernicious anemia in people over 60 is only about 1.9%, and that exclusion of subjects with clinically deficient vitamin B12 (<150 pmol/mL, the range expected in pernicious anemia) did not diminish the observed association of vitamin B12, it is unlikely that pernicious anemia is driving the association we observe. The one prior study of serum folate with gastric cancer within the EPIC cohort found no association between serum folate concentrations and overall gastric cancer risk or cardia gastric cancer risk. 15 In this study, we found an increased risk of EGJA with higher serum folate concentrations in just one model. While low folate has been shown to be protective against colorectal cancer in a population with low folate status, 43 with only 46 cases, the apparent EGJA-folate association should be interpreted with caution.
Our study had some notable limitations. The ATBC study was conducted in a cohort of male Finnish smokers, and therefore may not be generalizable to women or nonsmokers. However, most studies report no significant difference in serum vitamin B12 concentrations in smokers compared to nonsmokers. 44 Further limitations include the fact that assessment of the nutrients in this study occurred at a single point in time, so they may have changed over the course of the long follow-up period. The high prevalence of H. pylori in the population minimized our ability to adjust for it in our models, as did the low prevalence of low pepsinogen I status. Models including measures of H. pylori seropositivity and low pepsinogen I were therefore less stable than models without these variables, possibly due to homogeneity within the population.
A major strength of our study is that it is prospective: all serum one-carbon nutrients were measured prior to cancer diagnosis. The thorough baseline assessment of participants also allowed us to adjust for many confounders including H. pylori, pepsinogen I, alcohol consumption, cigarette smoking and education and assess the relevance of several more. Furthermore, the use of objective serum concentrations for the one-carbon factors, rather than self-reported nutrient intake, is likely a better indicator of absorbed and biologically active dose. This is particularly true of vitamin B12, for which >80% of deficiency states are due to malabsorption rather than insufficient dietary intake. 36 Our study also included a long follow-up time (17 years) and examination of the effect of nutrient concentrations over an extended period, allowing us to minimize the effects of potential preclinical disease at baseline on the exposure measure. In summary, we observed an increased risk of NCGA with decreasing serum concentrations of vitamin B12. Further studies should explore the utility of vitamin B12 as a serologic marker of gastric atrophy.
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